This is a news story, published by CBS News, that relates primarily to FDA news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CBS News, you can click here:
more news from CBS NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
fentanyl lollipops. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest TIRF medications news, TIRF medicines news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
controversial fentanyl painkillerCBS News
•81% Informative
Drugmakers have decided to stop selling a kind of controversial fentanyl painkiller at the end of this month .
The FDA says there are fewer than 150 patients receiving treatment with TIRF medicines.
The end of sales of the drugs follows decades of investigations and investigations.
Patients who are currently on a one of these medicine may continue treatment while the supply is available.
VR Score
72
Informative language
66
Neutral language
74
Article tone
semi-formal
Language
English
Language complexity
66
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
9
Source diversity
6
Affiliate links
no affiliate links